Get started

RNA

KRRO a biotech company with earnings coming LONGKRRO is in the biotechnology space in the gene-editing realm. It is in portfolios of C. Woods . A recent analyst gave it an upside to 100 which is very favorable given its product line and track record with an all-time high of about $250 ( which is about 450% over current valuation) On the one-hour time frame, it has had a great week and is breaking out over its moving averages as well as bullish momentum on the dual TF RSI indicator. This is a stock-long trade in the biotechnology sector which is prognosticated to be among the best of 2024. The dramatic reversal on the chart tells me this is a long entry. Targeting $57.5 in the short term and $75.00 for most of the position in consideration of the analyst report.
NASDAQ:KRROLong
by AwesomeAvani
1
Avidity Biosciences (RNA) Analysis RNA Therapeutics Leadership: Avidity Biosciences NASDAQ:RNA is at the forefront of RNA therapeutics with its innovative antibody-oligonucleotide conjugates (AOCs). Its lead candidate, Del-desiran (AOC 1001), targeting myotonic dystrophy type 1, is on the verge of a pivotal trial. Approval could significantly boost earnings. Strategic Partnership: Avidity's partnership with Bristol Myers Squibb, valued at up to $2.3 billion, focuses on cardiovascular targets, expanding their collaboration and enhancing the potential for groundbreaking treatments. Clinical Milestones: A major clinical update for AOC 1001 is expected by mid-2025. Success in this trial could validate Avidity’s platform and unlock significant value. Additionally, the company is developing treatments for Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD). Investment Outlook: Bullish Outlook: We are bullish on RNA above the $24.00-$24.50 range. Upside Potential: With a target set at $34.00-$35.00, Avidity's innovative approach and diversified pipeline present significant growth potential. 📊🧬 Stay informed about Avidity Biosciences for promising investment opportunities! #RNA #Therapeutics 📈🔍
NASDAQ:RNALong
by Richtv_official
BNTC Gene Therapy Penny Stock at All Time LowBNTC Benitec Biopharma Inc is a development-stage biotechnology company which focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics. BlackRock Inc., Renaissance Technologies LLC, Vanguard Group Inc. and Morgan Stanley have stakes in it. On 2/17/2022 P. Trucchio from HC Wainwright brokerage Initiated Coverage for BNTC with a Buy rating and a price target of $10.00. The price of the stock can easily double in my opinion.
NASDAQ:BNTCLong
by TopgOptions
1
BNTC Gene Therapy Penny StockBTC Benitec Biopharma is sitting now at a key support from which we can expect a bounce. We know that earlier this year they had a 7.5mil offering price to the public of $4.25 per share and that Morgan Stanley has a 5.2% stake in the genetic drug company. Benitec's "proprietary platform, called DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitate sustained silencing of disease-causing genes following a single administration. Market Cap 22.472Mil My price targets are 4.70 and 5.70 usd.
NASDAQ:BNTCLong
by TopgOptions
The biotech era possibilities: reverse aging, cure cancer, ...A little intro to the biotech cycle... It could be real big. RNA technology can do a little bit more than tell your genes to produce spike protein. It could be used to fight cancer. It could also be used to increase life expectancy from 75 years to perhaps 90. And more importantly, make people age slower as well as kill "deficient" cells involved in aging. This means "prime" and "old age" would go from 25-50 and 50-75 to 25-60 and 60-90. Can you imagine? Of course this is not eternal life, but us humans prime for what seems like such a short time, especially as our life expectancy increase. You get to 25 and it's a race. By 50 it's over. At 35 you're already basically halfway through and missed on so much prossibly. But if you got until 60 then it would make a significant difference. You life would not be "over" just a few years after reaching adulthood. A while ago they came up with solutions but they had a little downside: it was highly cancerigenous. Research has improved, and if people don't revert to the stone age soon (no guarentee about that), it will continue. Plenty of treatments (injections, drugs, not RNA modifications) have been tested, and we have seen "70 year old" mice run faster than "25 year olds". They have been tested on various mammals and plants. And to my knowledge, 1 human. David Sinclair, a genetician that looks at least 10 years younger than he is. Not going to lie, the first people to get access to this, after the innovators (the few professors testing it on themselves) will be rich people. Anti-ageing through DNA therapy got to be cheaper and work better than weekly injections of 5 products + 25 other products to counter the side effects. RNA also is used to fight rare diseases, genetic disorders, but this concerns a tiny part of the population. It's nice and all, but let's be honest, most people care way more about increasing everyone's (and their) healthy life spans. Other uses: Vaccines. Obviously. Hunger management (you could also just ban obesity like Japan or ban the industry from dumping trucks of sugar and salt in their food to make people hungry). Faster fracture repair (maybe send gene instructions temporarly) Cure all sorts of handicaps (up to 10% of the population) Less very dumb people (that are unemployable)? Hair loss Color blindness Finally fix these teeth constantly getting damaged by bacteria Regrow an arm? Some cool sci-fi stuff? X-ray vision maybe? Idk unlimited possibilities A huge market bubble since "unlimited possibilities" Oh I can already see it Right now they are showing the population that RNA tech isn't scary by using them all (most of the pop) as guinea pigs and force vaccinating a lot of people. But I think they are calming down. These guys aren't that bright but at some point they might figure out if they insist too much they will alienate people and make them ultra-conservative and anti-vaxx and anti-everything. The boomers in power don't have long, so of course they are in a hurry to push this tech at any cost. Funny. They are desperate. The only western president that is young is Macron and OF COURSE his wife is like 80 or something. The risk is MOAR mass hysteria, MORE euphorism, so I think ultimately people will get greedy and go after more and more half tested rushed treatments, and traders should know the outcome: eventually, a catastrophe. Mass deaths followed by reverting back to ultra conservative values. Good buy on the next major bear market (this company or whichever one survives). But investing in this is not even the most interesting part.
NASDAQ:MRNA
by MrRenev
1